Janssen is set to kick off commercial production following a new €300m manufacturing suite and is set to expand further in Cork. The Pharma company is set to create 180 new full-time positions in engineering, facilities, manufacturing, regulatory affairs, and quality.
A part of Johnson & Johnson, the company is expanding its biopharmaceutical supply chain facility in Ringaskiddy in Cork. The construction on the €150m expansion started earlier in the year and the work is predicted to take around two years to finish.
In addition to the 180 full-time roles, the expansion will create, around 300 people will be hired for the construction stage of the project. Leo Varadkar, Minister for Enterprise, Trade, and Employment has said this is great news for patients worldwide and people in Cork.
Janssen’s Cork expansion will add to its existing worldwide manufacturing capacity, enabling the business to reach patients faster with important medicines. The Cork site creates medicines for oncology and immunology patients. It has been in place since 2005 and now has a workforce of over 700 individuals.
In 2020, the facility was considered a Global Lighthouse site by the World Economic Forum due to its adoption of industry 4.0 technologies. The Cork site acts as a worldwide centre of excellence for drug product release, clinical drug substance, and stability management. Not to mention, it also hosts R&D programmes to support the rollout of new medicines to the Johnson & Johnson supply chain.
